{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T09:28:44Z","timestamp":1697448524849},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.vaccine.2005.07.058","type":"journal-article","created":{"date-parts":[[2005,8,9]],"date-time":"2005-08-09T11:30:18Z","timestamp":1123587018000},"page":"819-825","source":"Crossref","is-referenced-by-count":4,"title":["Phenotypic assessment of Neisseria meningitidis isolates obtained from patients with invasive meningococcal disease in Greece, 1993\u20132003: Implications for serogroup B vaccines based on PorA serosubtype antigens"],"prefix":"10.1016","volume":"24","author":[{"given":"Georgina","family":"Tzankaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fani","family":"Markou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Kesanopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stamatina","family":"Levidiotou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Pangalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariza","family":"Tsolia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassiliki","family":"Liakou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Papapavasiliou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliki","family":"Voyiatzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athina","family":"Kansouzidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Foustoukou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Blackwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Kremastinou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.07.058_bib1","unstructured":"Health Protection Agency. Two teenagers die in an outbreak of meningococcal disease in Rotherham. Commun Dis Rep Wkly 1999;9:9."},{"key":"10.1016\/j.vaccine.2005.07.058_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/jama.273.5.383","article-title":"Serogroup C meningococcal outbreaks in the United States. An emerging threat","volume":"273","author":"Jackson","year":"1995","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2005.07.058_bib3","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/oxfordjournals.aje.a008792","article-title":"Outbreak of serogroup C meningococcal disease associated with campus bar patronage","volume":"143","author":"Imrey","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2005.07.058_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1099\/jmm.0.04817-0","article-title":"Neisseria meningitidis phenotypic markers and septicaemia, disease progress and case fatality rate of meningococcal disease: a 20 year population-based historical follow-up study in a Danish county","volume":"52","author":"Jensen","year":"2003","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2005.07.058_bib5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1017\/S0950268802007549","article-title":"National enhanced surveillance of meningococcal disease in England, Wales and Northern Ireland, January 1999 and June 2001","volume":"129","author":"Shigematsou","year":"2002","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2005.07.058_bib6","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1086\/520303","article-title":"Complications and sequelae of meningococcal disease in Quebec, Canada, 1990\u20131994","volume":"26","author":"Erickson","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.058_bib7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/clinids\/7.4.504","article-title":"Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes","volume":"7","author":"Frasch","year":"1985","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.058_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1574-6968.1988.tb02366.x","article-title":"Definition of meningococcal class 1 OMP subtyping antigens by monoclonal antibodies","volume":"1","author":"Abdillahi","year":"1988","journal-title":"FEMS Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2005.07.058_bib9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1086\/515622","article-title":"Dynamics of carriage of Neisseria meningitidis in a group of military recruits","volume":"178","author":"Jones","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.058_bib10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1099\/00222615-43-5-335","article-title":"Antibodies to meningococcal class 1 outer-membrane protein and its variable regions in patients with systemic meningococcal disease","volume":"43","author":"Idanpaan-Heikkila","year":"1995","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2005.07.058_bib11","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1128\/IAI.63.12.4642-4652.1995","article-title":"Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine","volume":"63","author":"Rosenqvist","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.058_bib12","doi-asserted-by":"crossref","unstructured":"Peeters CCAM, R\u00fcmke HC, Sundermann LC, et al. Phase I clinical trial with a hexavalent porA containing meningococcal outer membrane vesicle vaccine. Vaccine 1996;14:1009\u201315 [context link].","DOI":"10.1016\/0264-410X(96)00001-1"},{"key":"10.1016\/j.vaccine.2005.07.058_bib13","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1128\/IAI.64.7.2745-2751.1996","article-title":"Specificity of human bactericidal antibodies against porA P1.7, 16 induced with a hexavalent meningococcal outer membrane vesicle vaccine","volume":"64","author":"van der Voort","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.058_bib14","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of 2 serogroup B outermembrane protein meningococcal vaccines: a randomised controlled trial in Chile","volume":"281","author":"Tappero","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2005.07.058_bib15","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1128\/IAI.71.4.1650-1655.2003","article-title":"Cross-reactivity of antibodies against PorA after vaccination with a meningococcal B outer membrane vesicle vaccine","volume":"71","author":"Vermont","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.058_bib16","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/S0264-410X(99)00044-4","article-title":"Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins","volume":"17","author":"Cartwright","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.058_bib17","unstructured":"Kieft C, Martin D, Baker M. The epidemiology of meningococcal disease in New Zealand in 1999. Report prepared for the ministry of Health by the Institute of Envivonmental Science and Research, Ltd. (ESR) New Zealand Ministry of Health, Wellington, New Zealand. 2000."},{"key":"10.1016\/j.vaccine.2005.07.058_bib18","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1086\/514232","article-title":"Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among adults in Iceland","volume":"177","author":"Perkins","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.058_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1574-695X.1999.tb01716.x","article-title":"Recent emergence of serogroup C meningococcal disease in Greece","volume":"23","author":"Kremastinou","year":"1999","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2005.07.058_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0928-8244(03)00175-5","article-title":"Evaluation of diagnosis of invasive meningococcal disease by polymerase chain reaction","volume":"39","author":"Tzanakaki","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2005.07.058_bib21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0928-8244(03)00083-X","article-title":"The evolving epidemiology of invasive meningococcal disease: a two-year prospective, population-based study in children in the area of Athens","volume":"36","author":"Tsolia","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2005.07.058_bib22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1574-6968.1987.tb02626.x","article-title":"Whole-cell ELISA for typing Neisseria meningitidis with monoclonal antibodies","volume":"48","author":"Abdillahi","year":"1987","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2005.07.058_bib23","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1016\/S0264-410X(01)00205-5","article-title":"Meningococcal disease in Europe: epidemiology, mortality and prevention with conjugate vaccines. Report of a European advisory board meeting","volume":"19","author":"Cartwright","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.058_bib24","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1128\/JCM.40.5.1834-1837.2002","article-title":"Invasive meningococcal disease in Scotland, 1994\u20131999, with emphasis on group B meningococcal disease","volume":"40","author":"Kyaw","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2005.07.058_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1099\/00222615-38-1-19","article-title":"Serogroups, serotypes and subtypes of Neisseria meningitidis isolated from patients and carriers in Greece","volume":"38","author":"Tzanakaki","year":"1993","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2005.07.058_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S0950268898001848","article-title":"Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe","volume":"122","author":"Connolly","year":"1999","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2005.07.058_bib27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/clind\/16.2.237","article-title":"Meningococcal disease in the Netherlands, 1950\u20131990: a steady increase in the incidence since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis","volume":"16","author":"Scholten","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.058_bib28","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/CDLI.2.3.314-321.1995","article-title":"Emergence of a new virulent clone within the electrophoretic type 5 complex of serogroup B meningococci in Norway","volume":"2","author":"Wedege","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2005.07.058_bib29","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1128\/JCM.42.11.5146-5153.2004","article-title":"Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway","volume":"42","author":"Yazdankhah","year":"2004","journal-title":"J Clin Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05007346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05007346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T19:56:38Z","timestamp":1586375798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05007346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0264410X05007346"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.07.058","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}